Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 5:8:545.
doi: 10.3389/fbioe.2020.00545. eCollection 2020.

Bacterial Lysates as Immunotherapies for Respiratory Infections: Methods of Preparation

Norma Suárez  1 , Florencia Ferrara  1 , Analia Rial  1 , Valerie Dee  1 , Jose A Chabalgoity  1
Affiliations
Review

Bacterial Lysates as Immunotherapies for Respiratory Infections: Methods of Preparation

Norma Suárez et al. Front Bioeng Biotechnol. .

Abstract

Bacterial lysates, prepared from the microorganisms most frequently involved in human Respiratory Tract Infections (RTIs) have been in the market for several decades, and at present, several different brands are available in many countries worldwide. They all claimed to exert local and systemic immunomodulatory effects but different clinical trials show disparate results between them. The lack of consistency of predicted therapeutic effects has undermined their clinical use and hampered licensing in several countries. One explanation for such lack of consistency in the results is that their methods of preparation are also very different. Here, we review the available literature describing methods of preparation of bacterial lysates, including patent disclosure documents. We found a great variety of methodologies of preparation and a lack of standardized procedures among them. The main conclusion of our study is that there is a clear need for standardized protocols of production to obtain comparable results in clinical trials worldwide.

Keywords: alkaline; bacterial lysates; bacteriophage; immunomodulator; mechanical; respiratory tract infections (RTIs); vaccine.

PubMed Disclaimer

References

    1. Aziminia N., Hadjipavlou M., Philippou Y., Pandian S. S., Malde S., Hammadeh M. Y. (2019). Vaccines for the prevention of recurrent urinary tract infections: a systematic review. BJU Int. 123, 753–768. 10.1111/bju.14606 - DOI - PubMed
    1. Bauer H. W., Rahlfs V. W., Lauener P. A., Bleßmann S. S. (2002). Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double- blind studies. Int. J. Antimicrob. Agents 19, 451–456. 10.1016/S0924-8579(02)00106-1 - DOI - PubMed
    1. Bauer J., Hirt P., Schulthess A. (1995). Extract of Bacterial Macromolecules, A Process for Its Preparation and a Pharmaceutical Composition Containing the Same [Internet]. US 00 5424287A. Available online at: https://www.google.com/patents/US5424287
    1. Bauer J. A., Salvagni M., Vigroox J.-P. L., Chalvet L., Chiavaroli C. (2008). Bacterial Extract for Respiratory Disorders and Process for iths Preparation [Internet]. WO 2008/109669 A2. Washington, DC: World Intellectual Property Organization; Available online at: http://www.freepatentsonline.com/8697154.html
    1. Bauer J. A., Salvagni M., Vigroox J.-P. L., Chalvet L., Chiavaroli C. (2010). Bacterial Extract for Respiratory Disorders and Process for its Preparation. U.S. Patent 0227013 A1. Washington, DC: U.S. Patent and Trademark Office.

LinkOut - more resources